Go to search feature Go to content

You need to use a different browser. To be able to use our internet services, you can instead use one of these browsers: Apple Safari, Google Chrome, Microsoft Edge or Mozilla Firefox.

Read more about recommended browsers

SEB Fund 3 - SEB Medical Fund’s merger with SEB Concept Biotechnology is now completed

The merger took effect on 21 April 2023 and is finalised.

The following funds, both Luxembourg-domiciled, were involved in the merger:

ยท         SEB Fund 3 - SEB Medical Fund merged with SEB Concept Biotechnology.

Now that the merger is effective, the SEB Fund 3 - SEB Medical Fund no longer exists. Customers who had investments in the SEB Fund 3 - SEB Medical Fund are encouraged to read the information about the merger that was published on this website on 7 March 2023.

Key Information Documents and prospectuses are available on www.sebgroup.lu/funds.

 Past performance does not guarantee future performance. The value of investment funds and other financial instruments may rise as well as fall and there is no guarantee you will recover your original investment. The SEB Concept Biotechnology fund is classified as a higher-risk fund and may, due to its composition and management methods, fall or rise sharply in value. 

I consent to given settings.